Amplo Biotechnology Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3M

  • Investors
  • 5

Amplo Biotechnology General Information

Description

Developer of adeno-associated viral (AAV) therapies designed to focus on cures for defects related to the neuromuscular junction. The company's therapies target defects in neuromuscular junction formation, such as paralysis, breathing, and swallowing difficulties, and are given via intravascular injection that triggers the activation of molecular events, enabling doctors to treat patients suffering from congenital myasthenic syndromes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2637 East Atlantic Boulevard
  • Suite 43644
  • Pompano Beach, FL 33062-4939
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2637 East Atlantic Boulevard
  • Suite 43644
  • Pompano Beach, FL 33062-4939
  • United States

Amplo Biotechnology Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amplo Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Sep-2024 $3M Completed Clinical Trials - General
4. Grant 01-Jun-2023 Completed Clinical Trials - General
3. Grant 01-Jun-2022 Completed Clinical Trials - General
2. Grant 28-Feb-2022 $254K $2.24M Completed Clinical Trials - General
1. Seed Round 01-Oct-2021 $2.24M $2.24M Completed Clinical Trials - General
To view Amplo Biotechnology’s complete valuation and funding history, request access »

Amplo Biotechnology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Amplo Biotechnology’s complete cap table history, request access »

Amplo Biotechnology Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
NIH Seed Not-For-Profit Venture Capital
U.S. Department of Health and Human Services Government
Biobrit Venture Capital Minority
Casdin Capital Venture Capital Minority
SeedFolio Venture Capital Minority
To view Amplo Biotechnology’s complete investors history, request access »

Amplo Biotechnology FAQs

  • When was Amplo Biotechnology founded?

    Amplo Biotechnology was founded in 2019.

  • Where is Amplo Biotechnology headquartered?

    Amplo Biotechnology is headquartered in Pompano Beach, FL.

  • What industry is Amplo Biotechnology in?

    Amplo Biotechnology’s primary industry is Drug Discovery.

  • Is Amplo Biotechnology a private or public company?

    Amplo Biotechnology is a Private company.

  • What is Amplo Biotechnology’s current revenue?

    The current revenue for Amplo Biotechnology is .

  • How much funding has Amplo Biotechnology raised over time?

    Amplo Biotechnology has raised $2.24M.

  • Who are Amplo Biotechnology’s investors?

    NIH Seed, U.S. Department of Health and Human Services, Biobrit, Casdin Capital, and SeedFolio have invested in Amplo Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process